Multiple Sclerosis
About the Disease
Multiple Sclerosis, also known as ms, is related to pediatric multiple sclerosis and autoimmune hepatitis, and has symptoms including back pain, headache and hemiplegia. An important gene associated with Multiple Sclerosis is HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1), and among its related pathways/superpathways are Phosphorylation of CD3 and TCR zeta chains and Cell differentiation - expanded index. The drugs Acetaminophen and Promethazine have been mentioned in the context of this disorder. Affiliated tissues include Neural Tube and Limb, and related phenotypes are spasticity and diplopia
Common Targets
G4573 | G2322 | G23765 | G51393 | G2597 | G84876 | G577 | G11343 | G23098 | G8514 | G2959 | G3902 | G1902 | G7704 | G241 | G8841 | G9315 | G11091 | G1235 | G3482 | G598 | C-C chemokine receptor (nonspecified subtype) | P6058 | G1586 | G1675 | G4846 | G25817 | G5535 | G3133 | G1723 | G4574 | G2902 | G3456 | G4217 | G7156 | G51561 | G27242 | G100506122 | G56834 | G117289 | G7046 | G2147 | G4914 | G5578 | G9370 | G3447 | G3786 | G7422 | G8740 | G923 | G163059 | G7498 | P48135 | G1543 | G7049 | G10956 | G11240 | G5802 | G6850 | G1803 | G1520 | G8797 | G29119 | G10346 | G10846 | G1111 | G6046 | G148867 | Matrix Metalloproteinase (MMP) (nonspecified subtype) | G1859 | G4261 | G7224 | G729230 | G2350 | G23534 | G5321 | G56848 | Voltage-gated K(v) channel (nonspecified subtype) | G4192 | G5533 | G5979 | G7097 | G3290 | G5778 | G124359 | G1381 | G406 | G7157 | G4514 | G4550 | G5770 | Hedgehog Protein (nonspecified subtype) | G8320 | G27063 | G7015 | G8470 | G105379656 | Tyrosine Kinase (nonspecified subtype) | G6532 | G10062 | G100861550 | G2932 | G958 | G6328 | G3605 | G4684 | Phospholipase A2 (nonspecified subtype) | G836 | G282617 | G8913 | G105370548 | G3163 | G3356 | G1646 | G5727 | G1139 | G1233 | G4321 | C-X-C Chemokine Receptor CXCR1/CXCR2 (IL-8 Receptor) (nonspecified subtype) | G10499 | G660 | G29943 | G10865 | G57605 | G590 | G3574 | IL-1 Receptor (nonspecified subtype) | G1493 | P6463 | G5467 | G2969 | G2159 | G105379664 | Neurotrophic Factor (nonspecified subtype) | Acetylcholine Receptors (Nicotinic) (nAChR) (nonspecified subtype) | G4313 | G7187 | G8600 | G8741 | G5481 | G29881 | G9722 | Thyroid hormone receptor (nonspecified subtype) | G7813 | G5295 | G27179 | G55254 | G1025 | G105375494 | G5479 | Protein Tyrosine Phosphatase (PTP) (nonspecified subtype) | G60674 | G6334 | G8722 | G55106 | G406928 | G19 | G929 | G965 | P5684 | G406947 | G4535 | G2357 | G84649 | G10144 | G331 | Glutamate Transporter (nonspecified subtype) | G116085 | Eukaryotic translation initiation factor 2-alpha kinase (nonspecified subtype) | G6509 | G10102 | G55255 | G57128 | G3135 | G80790 | G100137047 | G10538 | G3575 | G1514 | G753 | G100506457 | G960 | P5761 | G1503 | Integrin Receptor (nonspecified subtype) | G5054 | G51083 | G85363 | G56244 | G383 | G7410 | G775 | G8856 | P16126 | G4855 | G5152 | G4074 | G7919 | G26090 | G4985 | G8654 | G8997 | G10673 | G952 | G3783 | P6348 | G6868 | G117583 | G3717 | G4519 | G677 | G4158 | G200315 | G5156 | Mitogen-Activated Protein Kinase (nonspecified subtype) | G22941 | G23261 | G283587 | G5782 | G3815 | G949 | G6262 | G2582 | G8698 | G942 | G3428 | G140564 | G4579 | G8726 | G124976 | G200316 | G8091 | G9971 | G1236 | G3562 | P24881 | G6403 | G2272 | G7514 | G8742 | G105369166 | P5614 | G4170 | G2138 | G23180 | G54106 | G10106 | G9294 | G128853 | P5698 | G4296 | G4773 | G84296 | G5653 | G3577 | G7412 | G9020 | G339829 | G140578 | G7052 | G4249 | G7484 | G100127946 | G3674 | G3952 | Peroxisome Proliferator-Activated Receptors (PPAR) (nonspecified subtype) | G1633 | G51135 | G2903 | G2950 | G9542 | G57142 | G4137 | G4544 | G22839 | G93974 | G931 | G415116 | G4762 | G79885 | G107987429 | G11262 | G3458 | G407738 | G2672 | G10059 | G1066 | G1326 | G8989 | G2891 | Platelet-Derived Growth Factor Receptor (nonspecified subtype) | G5915 | G6198 | P19243 | G2166 | G25895 | G57674 | G50863 | G8743 | G1131 | G6573 | G1591 | G2033 | G4843 | G80216 | G283234 | G146433 | P5833 | G185 | G7099 | G84888 | G3122 | G9755 | G1191 | G3558 | G27086 | G3702 | G3718 | G649 | G2264 | G100 | G114548 | G3600 | G3716 | G5340 | G8826 | G90627 | G5734 | G3552 | P16964 | G4340 | G122402 | G408 | G1903 | G105371082 | G7018 | G3112 | G58513 | G5966 | G3741 | G706 | G23046 | G100287329 | P13024 | G2139 | G7428 | G79776 | G7174 | G51185 | G10110 | G581 | G4536 | G84159 | G9261 | G59283 | G221061 | G286676 | G7433 | G5428 | Interferon (nonspecified subtype) | Adenosine deaminase (nonspecified subtype) | P16740 | Myosin Class II (nonspecified subtype) | Histone deacetylase (nonspecified subtype) | G2194 | G4815 | G11113 | G158747 | G80351 | G8099 | G5314 | G55584 | G3336 | G3460 | G780 | G1234 | G356 | G3676 | G3748 | G79258 | G831 | G10461 | G3034 | G962 | G114818 | G728642 | G3753 | G1740 | G4521 | G7535 | G253782 | G9758 | G3269 | G6095 | G388650 | G3113 | G115350 | G664 | G167826 | G1043 | G5601 | G9475 | G6335 | P5867 | G6775 | G84894 | G85480 | G5580 | G696 | G200576 | G4316 | G50508 | G105377979 | Glycogen synthase kinase 3 (GSK-3) (nonspecified subtype) | G163702 | G214 | G10397 | G60468 | G7128 | G105375911 | G9657 | G11251 | G57623 | G405 | G7040 | G10301 | G5795 | G120227 | G3567 | G2066 | Heme Oxygenase (HO) (nonspecified subtype) | G152078 | G3798 | G719 | G5025 | G5327 | G2833 | G9759 | G58531 | G121260 | P13475 | KCNQ Channels (K(v) 7) (nonspecified subtype) | G196 | G90 | G9214 | G11184 | G4852 | G79132 | G5551 | G10507 | G348 | G5133 | G8893 | G10677 | G11274 | Interferon alpha/beta Receptor (nonspecified subtype) | G2023 | G4620 | G920 | G3565 | G3953 | G4322 | G10213 | G29108 | G5583 | G105375914 | Sphingomyelin phosphodiesterase (nonspecified subtype) | Pim Kinase (nonspecified subtype) | CDK6/Cyclin D1 | G1717 | G4690 | G321 | P11025 | P5662 | G823 | G54209 | G10060 | G5781 | G3784 | G1544 | G3990 | G1387 | Transforming growth factor beta (nonspecified subtype) | G3119 | G25 | G5292 | G57506 | G4035 | G4067 | G4537 | G5579 | G941 | G23304 | G1588 | Tankyrase (nonspecified subtype) | G6885 | G26191 | G5888 | G1308 | G3579 | G3777 | G57406 | G9887 | G1522 | G406938 | G84619 | G53831 | G875 | Phospholipase A2, Cytosolic (nonspecified subtype) | G337867 | G64900 | G164714 | Janus Kinase (nonspecified subtype) | G221895 | G23621 | G29123 | G2346 | G84898 | G970 | G596 | Poly [ADP-ribose] polymerase (nonspecified subtype) | G2262 | G4860 | G6256 | alpha1-Adrenoceptor (nonspecified subtype) | G7434 | G105378083 | G10682 | G6948 | G2918 | G92979 | Nitric oxide synthase (NOS) (nonspecified subtype) | G3358 | G116986 | G121278 | G144132 | Dopamine receptor (nonspecified subtype) | Potassium Channels (nonspecified subtype) | G2899 | P16179 | Cysteine Protease (nonspecified subtype) | G4282 | G22806 | G8452 | G55191 | G3663 | G3816 | G83871 | G9290 | G3362 | G5797 | G134145 | P33507 | G79722 | G5532 | G9563 | Sterol O-acyltransferase (ACAT) (nonspecified subtype) | G8019 | G53637 | G100049716 | G10038 | G57509 | G6531 | G718 | G27190 | G6523 | G2057 | G7166 | G7296 | G5315 | G5534 | G114 | Vascular endothelial growth factors (VEGF) (nonspecified subtype) | G81671 | G8288 | G10803 | G9891 | G1437 | G4210 | G5153 | G2740 | G3074 | G1230 | G177 | G7142 | G4555 | G10724 | G11026 | G79068 | G240 | G105371664 | G3115 | Kallikrein (nonspecified subtype) | G355 | G4129 | G10008 | G11122 | G6331 | G7054 | G2638 | G27198 | G6774 | G26130 | G5294 | G10135 | G285626 | P19878 | G2558 | G27346 | G10184 | G3107 | G6999 | G4292 | G2475 | G54795 | G340061 | G4538 | G54210 | G1029 | G5027 | G961 | G374868 | Cannabinoid receptor (nonspecified subtype) | G1880 | G728755 | G4988 | G5143 | G9262 | G9520 | G57633 | G335 | G3592 | G3939 | G4558 | G238 | G115557 | G6096 | G2913 | G3123 | G1195 | G728 | G23704 | G8877 | G5602 | G10636 | G3075 | G1436 | G64135 | 17-beta-Hydroxysteroid dehydrogenase (nonspecified subtype) | Leukotriene B4 receptor (LTB4-R) (nonspecified subtype) | Inosine 5'-monophosphate dehydrogenase (IMPDH) (nonspecified subtype) | G1636 | G4508 | G2146 | G4907 | G28514 | G3146 | P5859 | G3908 | G1719 | G51305 | G930 | G11103 | G3866 | G7226 | G83986 | G5243 | G9023 | G2911 | G29126 | G1513 | G1901 | G2203 | G23274 | G5328 | Fibroblast Growth Factor Receptor (FGFR) (nonspecified subtype) | Peptidylprolyl Isomerase (nonspecified subtype) | G130013 | G105376287 | G6347 | G3778 | G4317 | G51284 | G2580 | G8737 | G1728 | G41 | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) (nonspecified subtype) | G608 | G1410 | G151888 | G3818 | G2081 | G9582 | G115650 | G7092 | G51752 | G2648 | G5588 | G10563 | G338 | G343450 | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7 (nonspecified protein) | G4548 | G834 | G55512 | G105376391 | G3091 | G695 | G26279 | G10013 | G10406 | G3099 | G3162 | G140685 | G1956 | G81552 | G1269 | G2904 | G940 | G3454 | G101928354 | G10293 | G9365 | G10663 | G9501 | G9992 | G7048 | G4312 | G2149 | G5055 | G8808 | G100913187 | G5696 | G3627 | G1508 | G3976 | Rho kinase (ROCK) (nonspecified subtype) | G4780 | G48 | Phospholipase A2, Secretory (sPLA2) (nonspecified subtype) | G7941 | G5141 | G4524 | G5648 | G3654 | G4036 | G10000 | G8927 | G3066 | G595 | G3606 | G64411 | G57476 | Focal Adhesion Kinases (FAK) (nonspecified subtype) | G10019 | G10437 | G7124 | G101928376 | G338442 | G105376481 | G3756 | G5008 | G5468 | G10371 | G6364 | G3790 | G4539 | G5290 | G23312 | G117154 | G149233 | G4155 | G4915 | G1240 | G1545 | G7132 | G4790 | G3106 | G60489 | Chemokine receptor (nonspecified subtype) | G3620 | G1593 | G200734 | G105372146 | Retinoid RXR receptor (nonspecified subtype) | G7093 | G79841 | G9180 | G3292 | G3736 | G6804 | G710 | G943 | G120425 | P40377 | Phosphodiesterase IV (PDE4) (nonspecified subtype) | G4353 | G2247 | G100131814 | G285704 | G1022 | G2914 | G3557 | G6714 | G290 | G2908 | Dual Specificity Mitogen-Activated Protein Kinase Kinase (MEK) (nonspecified subtype) | G730100 | G5144 | G3945 | G4048 | G2058 | G4323 | G4540 | G4986 | G5788 | G1352 | G974 | G3481 | G27163 | G5581 | Phosphodiesterase (nonspecified subtype) | G627 | G80024 | G50943 | G341359 | G1524 | G3804 | P6747 | G8639 | G5465 | G1017 | G117194 | G3569 | G735 | G4929 | G79970 | G5160 | G93107 | G11277 | P8262 | G2167 | G1019 | G3604 | G5364 | G100505573 | G10495 | G11255 | G59340 | G1268 | G64067 | P5758 | G3956 | G2896 | G56729 | G5724 | G5743 | G116379 | G6097 | P29419 | G3837 | G29110 | G3455 | G6288 | Calcium channel (nonspecified subtype) | Mitogen-activated protein kinase (JNK) (nonspecified subtype) | G5619 | G3785 | G2261 | G4803 | G2266 | G5732 | Neurotensin receptor (nonspecified subtype) | G60495 | G1594 | G51056 | G10665 | G3305 | P16683 | G7442 | G8174 | G6326 | G6506 | G207 | G27306 | G285830 | G57540 | G64359 | G79671 | P16165 | P6884 | G4126 | G7297 | G23637 | G51311 | G54567 | G5620 | G6188 | G1312 | G6369 | Heat shock protein 90 (nonspecified subtype) | G6556 | G839 | G5478 | G3593 | G142 | G646982 | G55454 | G9531 | G120892 | G79054 | G285195 | G56963 | G143 | G146177 | G160728 | G23095 | G5168 | G5293 | Collagenase (nonspecified subtype) | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | G43 | G7150 | G977 | P5759 | G6622 | Protein kinase C (nonspecified subtype) | G6812 | G2099 | G23495 | G8811 | Ras GTPase (nonspecified subtype) | G6401 | G5329 | G105374910 | P5767 | G100616384 | G57178 | G5139 | P11049 | G6336 | G3630 | G3737 | G6530 | G6696 | G6861 | G4179 | G5445 | G3065 | G3560 | G151306 | G6891 | G80036 | G8487 | G8795 | G8847 | G2840 | G5742 | G58191 | G3791 | G50614 | G3293 | G3350 | G2852 | G6608 | G2581 | G7294 | G23476 | G868 | Monoamine oxidase (MAO) (nonspecified subtype) | Interleukin 17 (nonspecified subtype) | G4233 | G7916 | G8767 | G54838 | G5621 | G9575 | Myelin Protein (nonspecified subtype) | P6320 | G4128 | G2735 | Protein Kinase B (PKB/Akt) (nonspecified subtype) | P5755 | G105372631 | G11083 | G4512 | G727 | G7421 | G5142 | G5150 | G2693 | G91662 | G56731 | G3553 | G23586 | G5320 | G3745 | G2053 | G222659 | G54587 | G5586 | G9863 | P44516 | P5681 | G1445 | Alpha-2 Adrenergic receptors (nonspecified subtype) | G400506 | G717 | G10666 | CDK4/Cyclin D1 | G2100 | G50615 | G80149 | G100996583 | G9900 | G57491 | G6261 | G629 | G4854 | G4921 | G100192386 | G107986041 | G4541 | G5599 | G3077 | G959 | G10858 | Sodium channel (nonspecified subtype) | G2063 | G7292 | G2280 | G3148 | G1232 | G1380 | P40594 | G3820 | G4615 | G3117 | G11040 | P29647 | G1509 | G7037 | G7852 | G8850 | G3559 | G1454 | G64848 | G432 | G2113 | G22933 | G8658 | G2915 | G6125 | Peptidyl arginine deiminase (PAD) (nonspecified subtype) | G2335 | G10198 | G5550 | G344148 | G84456 | G5820 | Tyrosine-Protein Kinases Src (nonspecified subtype) | G3738 | G6571 | G7276 | G2150 | G4851 | G54806 | P5760 | G4318 | G79071 | G3551 | G23411 | G10800 | G1440 | G8879 | G3821 | G840 | G84570 | G10892 | G8202 | G10320 | Folate Receptor (nonspecified subtype) | G140733 | G1432 | G642987 | G7068 | G2993 | G3156 | Asialoglycoprotein Receptor (ASGPR) (nonspecified subtype) | Interleukin-1 receptor-associated kinase (IRAK) (nonspecified subtype) | G3958 | G4234 | G8975 | G9536 | G3320 | Kainate Receptor (GluR) (nonspecified subtype) | G124152 | G6376 | G29994 | G613 | G643 | G414764 | G4314 | G8651 | G1128 | G1132 | G6093 | G2688 | G102723878 | Lipoxygenase (nonspecified subtype) | G1404 | G7006 | G4513 | G3586 | Estrogen receptor (nonspecified subtype) | G23569 | G139760 | G367 | G4842 | G4938 | G9187 | P10238 | G4162 | G4549 | G5291 | G9817 | G11172 | Serine/threonine-protein kinase (PAK) (nonspecified subtype) | Metabotropic glutamate (mGluR) receptor (nonspecified subtype) | G4609 | G7376 | G92291 | P5683 | G5241 | Calpain (nonspecified subtype) | G3932 | Ribonucleoside-diphosphate reductase | G4049 | G253461 | G8379 | G3105 | Interleukin-1 (nonspecified subtype) | DNA Topoisomerase II (nonspecified subtype) | G100133941 | G2826 | G6423 | G7295 | G23435 | G3383 | G340069 | G864 | G3294 | G3357 | G135 | Lysophospholipid (edg) Receptors (nonspecified subtype)
The "Target / Biomarker Review Report" is a comprehensive and customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about the Target(s) / Biomarker(s) of your choice related to Multiple Sclerosis, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
Other Diseases
Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapsing-remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sulfatase Deficiency | Multiple System Atrophy | Multisystemic Smooth Muscle Dysfunction Syndrome | Mumps | Muscle Wasting | Muscular Dystrophy | Myasthenia | Myasthenia Gravis | Mycosis Fungoides | Myelitis | Myelitis, Transverse | Myelodysplasia | Myelofibrosis | Myeloid Leukemia | Myelomeningocele | Myhre Syndrome | Myocardial Infarction | Myocarditis | Myoclonic Atonic Epilepsy | Myoclonic Epilepsy With Ragged Red Fibers | Myoclonus | Myoclonus-dystonia Syndrome | Myofibrillar Myopathy | Myofibromatosis | Myopathy | Myopia | Myosin Storage Myopathy | Myositis | Myositis, Focal | Myotonia | Myotonic Disorders | N-acetylglutamate Synthase Deficiency | Nager Acrofacial Dysostosis | Nail Disorder, Nonsyndromic Congenital | Nail-Patella Syndrome | Nance-Horan Syndrome | Nanophthalmos | Narcolepsy | Nasodigitoacoustic Syndrome | NDH Syndrome | Necrobiosis Lipoidica | Necrotizing Autoimmune Myopathy | Nemaline Myopathy | Nemaline Myopathy 10 | Nemaline Myopathy 8 | Neonatal Progeroid Syndrome | Neovascular Glaucoma | Nephritis, Interstitial | Nephroblastoma | Nephrocalcinosis | Nephronophthisis | Nephropathy | Nephrosclerosis | Nephrotic Syndrome | Nephrotic Syndrome Type 1 | Nestor-Guillermo Progeria Syndrome | Netherton Syndrome | Neural Tube Defect | Neuroblastoma | Neurocutaneous Melanocytosis | Neurocutaneous Syndromes | Neurocysticercosis | Neurodegeneration Due To Cerebral Folate Transport Deficiency | Neurodegeneration With Brain Iron Accumulation | Neurodermatitis | Neurodevelopmental Disorder With Central Hypotonia And Dysmorphic Facies | Neurodevelopmental Disorders | Neuroectodermal Tumors, Primitive | Neuroendocrine Cancer | Neurofibroma | Neurofibroma, Plexiform | Neurofibromatosis | Neurofibromatosis Type 1 | Neurofibromatosis Type 2 | Neurofibromatosis-Noonan Syndrome | Neurofibrosarcoma | Neurogenic Bladder | Neuroleptic Malignant Syndrome | Neuroma | Neuromuscular Disorders | Neuromyelitis Optica | Neuromyotonia | Neuronal Ceroid Lipofuscinosis | Neuropathy | Neurotoxicity | Neutropenia | Neutrophilia | Nevus | NGLY1 Deficiency | Nicolaides-Baraitser Syndrome | Nicotine Addiction | Nicotine Dependence | Niemann-Pick Disease | Niemann-Pick Disease, Type A | Niemann-Pick Disease, Type B | Niemann-Pick Disease, Type C | Nijmegen Breakage Syndrome | Non-bullous Congenital Ichthyosiform Erythroderma | Non-epidermolytic Palmoplantar Keratoderma | Non-Hodgkin Lymphoma | Non-Langerhans Cell Histiocytosis | Non-proliferative Diabetic Retinopathy | Noonan Syndrome | Noonan Syndrome-like Disorder With Loose Anagen Hair | Norrie Disease | Nutrition Disorders | Obesity | Obesity, Morbid | Obsessive-compulsive Disorder | Occipital Neuralgia | Ocular Albinism Type 1 | Ocular Hypertension | Ocular Surface Squamous Neoplasia | Oculocutaneous Albinism | Oculocutaneous Albinism Type 1 | Oculocutaneous Albinism Type 2 | Oculocutaneous Albinism Type 4 | Oculodentodigital Dysplasia | Oculopharyngeal Muscular Dystrophy | Odonto-onycho-dermal Dysplasia | Oguchi Disease-2 | Okihiro Syndrome | Oligoasthenoteratozoospermia | Oligoastrocytoma | Oligodendroglioma | Oligospermia | Ollier Disease | Olmsted Syndrome | Omenn Syndrome | Onchocerciasis | Open-angle Glaucoma | Ophthalmia, Sympathetic | Ophthalmoplegia | Opisthorchiasis | Optic Atrophy 2 | Optic Nerve Diseases | Optic Nerve Hypoplasia, Bilateral | Optic Neuritis | Optic Neuropathy | Optic Neuropathy, Anterior Ischemic | Oral Lichen Planus | Ornithine Transcarbamylase Deficiency | Orotic Aciduria | Orthostatic Intolerance | Osmotic Demyelination Syndrome | Osteitis | Osteoarthritis | Osteochondroma | Osteochondrosis | Osteogenesis Imperfecta | Osteogenesis Imperfecta Type I | Osteogenesis Imperfecta Type II | Osteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IV | Osteogenesis Imperfecta Type V | Osteogenesis Imperfecta Type VI | Osteoglophonic Dysplasia | Osteomalacia | Osteomyelitis | Osteonecrosis | Osteonecrosis Of The Jaw | Osteopathia Striata With Cranial Sclerosis | Osteopetrosis | Osteoporosis | Osteoporosis, Postmenopausal | Osteoporosis-pseudoglioma Syndrome | Osteosarcoma | Osteosclerosis | Otitis Externa | Otitis Media | Otopalatodigital Syndrome Type 2 | Otosclerosis | Ovarian Hyperstimulation Syndrome | Ovarian Sex Cord-stromal Tumor | Overactive Bladder | Pachyonychia Congenita | Paget's Disease Of The Breast | Pain | Palmoplantar Keratoderma | Palsy, Cerebral | Pancreatitis | Pancreatitis, Chronic | Pancytopenia | Panic Disorder | Panniculitis | Pantothenate Kinase-associated Neurodegeneration | Panuveitis | Papilledema | Papilloma | Papillon-Lefevre Syndrome | Papillorenal Syndrome | Papulopustular Rosacea | Paracoccidioidomycosis | Paraganglioma | Paraganglioma, Carotid Body | Paraplegia | Parapsoriasis | Parkinson Disease 6, Autosomal Recessive Early-onset | Parkinson's Disease | Parkinsonism | Paronychia | Paroxysmal Kinesigenic Dyskinesia | Paroxysmal Nocturnal Hemoglobinuria | Partington Syndrome | Parvovirus B19 Infection | PASLI Disease | Patent Ductus Arteriosus | Patent Foramen Ovale | Paternal Uniparental Disomy Of Chromosome 14 | Pathological Gambling | Pearson Syndrome | Peeling Skin Syndrome Type B | Peeling Skin Syndrome, Acral Type | Pelizaeus-Merzbacher Disease | Pelvic Inflammatory Disease | Pemphigoid | Pemphigus | Pemphigus Foliaceus | Pemphigus Vulgaris | Pendred Syndrome | Pericarditis | Periodic Limb Movement Disorder | Periodontitis | Peripheral Neuropathy | Peripheral T-cell Lymphoma | Peritonitis | Perivascular Epithelioid Cell Tumor | Periventricular Leukomalacia | Periventricular Nodular Heterotopia | Pernicious Anemia | Peroxisomal Disorder | Perry Syndrome | Persistent Fetal Circulation | Persistent Hyperplastic Primary Vitreous | Persistent Mullerian Duct Syndrome | Persistent Truncus Arteriosus | Personality Disorders | Peters-plus Syndrome | Peutz-Jeghers Syndrome | Peyronie's Disease | Pfeiffer Syndrome | PHARC Syndrome | Phenylketonuria | Phenylketonuria II | Pheochromocytoma | Phosphoenolpyruvate Carboxykinase Deficiency, Cytosolic | Phosphoglycerate Dehydrogenase Deficiency | Photosensitivity | Pierpont Syndrome | Pierre Robin Syndrome | Pierson Syndrome | Pigment Dispersion Syndrome | Pilomatrix Carcinoma | Pineoblastoma | Pitt-Hopkins Syndrome | Pituitary Disorders | Pituitary Dwarfism | Pituitary Stalk Interruption Syndrome | Pityriasis Rubra Pilaris | Placenta Previa | Plasma Cell Dyscrasia | Plasma Cell Leukemia | Plasmacytoma | Platelet Disorders | Platyspondylic Lethal Skeletal Dysplasia, Torrance Type | Pleomorphic Xanthoastrocytoma | Pleural Tuberculosis | Pleurisy | Pneumococcal Meningitis | Pneumoconiosis | Pneumonia, Bacterial | Pneumonia, Mycoplasma | Pneumonia, Viral | Pneumothorax | POEMS Syndrome | Poikiloderma With Neutropenia | Poirier-Bienvenu Neurodevelopmental Syndrome | Polyarteritis Nodosa | Polycystic Kidney, Autosomal Dominant | Polycystic Kidney, Autosomal Recessive | Polycystic Liver | Polycystic Ovary Syndrome | Polycythemia | Polycythemia Vera | Polydactyly | Polymicrogyria | Polymyalgia Rheumatica | Polymyositis | Polyneuropathy | Polyomavirus Nephropathy | Polyradiculopathy | Pompe Disease | Pontocerebellar Hypoplasia | Pontocerebellar Hypoplasia Type 2 | Pontocerebellar Hypoplasia Type 7 | Porencephaly | Poretti-Boltshauser Syndrome | Porokeratosis | Porphyria | Porphyria Cutanea Tarda | Porphyria, Acute Intermittent | Porphyria, Variegate | Portal Vein Thrombosis | Postaxial Polydactyly | Posterior Polar Cataract | Postpartum Depression | Postpoliomyelitis Syndrome | Potocki-Shaffer Syndrome | Pouchitis | Prader-Willi Syndrome | Pre-eclampsia | Preaxial Polydactyly | Precocious Puberty | Prediabetes | Pregnancy, Ectopic | Premature Ejaculation | Premenstrual Syndrome | Presbycusis | Presbyopia | Priapism | Primary Aldosteronism | Primary Biliary Cholangitis | Primary Carnitine Deficiency | Primary Cutaneous Amyloidosis | Primary Erythromelalgia | Primary Familial Brain Calcification | Primary Hyperoxaluria | Primary Hyperoxaluria Type 1 | Primary Hyperoxaluria Type 3 | Primary Lateral Sclerosis | Primary Ovarian Insufficiency | Primary Pigmented Nodular Adrenocortical Disease | Primary Progressive Aphasia | Primary Progressive Nonfluent Aphasia | Primary Sclerosing Cholangitis | Primary Torsion Dystonia | Primrose Syndrome | Proctitis | Progressive Encephalopathy-optic Atrophy Syndrome | Progressive External Ophthalmoplegia | Progressive Familial Intrahepatic Cholestasis | Progressive Familial Intrahepatic Cholestasis Type 1 | Progressive Familial Intrahepatic Cholestasis Type 2 | Progressive Familial Intrahepatic Cholestasis Type 3 | Progressive Myoclonic Epilepsy | Progressive Osseous Heteroplasia | Prolactinoma | Prolidase Deficiency | Prolymphocytic Leukemia | Proopiomelanocortin Deficiency | Prostatitis | Proteasome-associated Autoinflammatory Syndrome 2 | Protein C Deficiency | Protein S Deficiency | Proteus Syndrome | Proximal Symphalangism | Prune Belly Syndrome | Prurigo Nodularis | Pseudo-pseudohypoparathyroidism | Pseudoachondroplasia | Pseudoexfoliation Syndrome | Pseudohermaphroditism | Pseudohypoaldosteronism | Pseudohypoparathyroidism Type 1A | Pseudohypoparathyroidism Type 1B | Pseudohypoparathyroidism Type 1C | Pseudohypoparathyroidism Type 2 | Pseudomyxoma Peritonei | Psoriasis | Pterygium | Pulmonary Alveolar Microlithiasis | Pulmonary Alveolar Proteinosis | Pulmonary Capillary Hemangiomatosis | Pulmonary Sclerosing Hemangioma | Pulmonary Stenosis | Pulmonary Tuberculosis | Pulmonary Vein Stenosis | Pulmonary Veno-occlusive Disease | Pulverulent Zonular Cataract | Pupil Disorders | Pure Autonomic Failure | Pure Red Cell Aplasia | Purpura | Purpura, Thrombotic Thrombocytopenic | Pycnodysostosis | Pyelonephritis | Pyloric Stenosis, Infantile Hypertrophic | Pyoderma Gangrenosum | Pyruvate Carboxylase Deficiency Disease | Pyruvate Decarboxylase Deficiency | Pyruvate Dehydrogenase Deficiency | Pyruvate Kinase Deficiency | Raine Syndrome | Rash | Raynaud Phenomenon | Recurrent Respiratory Papillomatosis
